STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLDB
  4. [EFFECT] Solid Biosciences Inc. SEC Filing

[EFFECT] Solid Biosciences Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 31, 2026 4:30 P.M.
Form: S-3
CIK: 0001707502
Company Name: Solid Biosciences Inc.
File Number: 333-294456

Source: View Original Filing on SEC EDGAR

Solid Bioscience

NASDAQ:SLDB

View SLDB Stock Overview →

SLDB Rankings

#3092 Ranked by Market Cap
N/A Ranked by Dividends

SLDB Latest News

Mar 19, 2026
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 11, 2026
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Mar 6, 2026
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
Mar 6, 2026
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Mar 2, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLDB Latest SEC Filings

Apr 2, 2026
[Form 4] Solid Biosciences Inc. Insider Trading Activity
Apr 1, 2026
[EFFECT] Solid Biosciences Inc. SEC Filing
Mar 19, 2026
[S-3] Solid Biosciences Inc. Shelf Registration Statement
Mar 19, 2026
[S-3] Solid Biosciences Inc. Shelf Registration Statement
Mar 19, 2026
[10-K] Solid Biosciences Inc. Files Annual Report

SLDB Stock Data

708.42M
65.05M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
CHARLESTOWN